Zee Entertainment shares jumped after receiving government approval for a Rs 418 crore foreign investment from an Invesco-managed fund. Thi...

Walt Disney's Star Group injected Rs 123 crore into JioStar India via FDI, bolstering the Reliance-Disney joint venture. This follows subst...

Telangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...

India's economy faces potential exchange rate volatility due to rising oil prices and supply chain issues, an RBI report revealed. Despite ...

India's insurance regulator has greenlit two proposals for 100% foreign ownership in general insurance firms, following the government's FD...

Zee Entertainment has secured a significant Rs 418 crore foreign investment from OFI Global China Fund LLC, marking the fund's return after...

Indian markets ended lower as Sensex and Nifty snapped a two-session winning streak, pressured by geopolitical tensions in the Middle East ...

Indian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...

Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...

Any moderation in El Nino effects and resolution of geopolitical uncertainty will further reduce the downside risks to growth. Operationali...

Strides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...

India is experiencing a pivotal shift in its financial markets as domestic investors take the lead over foreign entities, enduring a three-...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

Sensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...

Chinese investments and technology are welcome in India, but a cautious approach is needed for trade, according to CII President R Mukundan...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

India is poised to gain from global supply chain shifts. Strategic neutrality and domestic focus are key. The nation must build robust buff...